Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHarvey Nash Group Regulatory News (HVN)

  • There is currently no data for HVN

Director/PDMR Shareholding

29 Oct 2018 07:00

RNS Number : 3880F
Harvey Nash Group PLC
29 October 2018
 

29 October 2018

 

Director/PDMR Shareholding

Harvey Nash Group Plc

("the Company")

Notification of Transaction by Directors

In accordance with DTR 3.1 and Article 19 of The Market Abuse Regulation, the Company was advised on 26 October 2018 that Albert Ellis, Simon Wassall and Mark Garratt had acquired ordinary shares in London on 26 October 2018 at a price of £0.05 per ordinary share as a result of the exercise of options granted under the Company's Performance Share Plan which became exercisable as a result of the offer by The Power of Talent Ltd being declared wholly unconditional on 26 October 2018:

Director

Number of shares purchased

Price per share

Resulting holding

Albert Ellis

1,385,499

£0.05

2,267,084*

Simon Wassall

930,215

£0.05

1,259,331

Mark Garratt

381,229

£0.05

416,787

*Includes 658,923 ordinary shares held by family members.

The notification below provides further detail.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them. 

1

Details of the person discharging managerial responsibility

a)

Name

Albert Ellis

2

Reason for the notification

a)

Position/status

Chief Executive

 

b)

Initial notification/amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Full name of the entity

Harvey Nash Group plc

b)

Legal Entity Identifier Code

2138004ULQUX3DQSCV07

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of £0.05 each

ISIN: GB0006573546

c)

Nature of the transaction

Acquisition through Company Performance Share Plan.

e)

Price(s) and Volume(s)

Exercise:

Price(s) per share

Volume(s)

Aggregate Price

£0.05

1,385,499

£69,274.95

 

 

 

g)

Date of transaction

26 October 2018

h)

Place of transaction

London Stock Exchange XLON

 

1

Details of the person discharging managerial responsibility

a)

Name

Simon Wassall

2

Reason for the notification

a)

Position/status

European Managing Director

 

b)

Initial notification/amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Full name of the entity

Harvey Nash Group plc

b)

Legal Entity Identifier Code

2138004ULQUX3DQSCV07

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of £0.05 each

ISIN: GB0006573546

c)

Nature of the transaction

Acquisition through Company Performance Share Plan.

e)

Price(s) and Volume(s)

Exercise:

Price(s) per share

Volume(s)

Aggregate Price

£0.05

930,215

£46,510.75

 

 

 

g)

Date of transaction

26 October 2018

h)

Place of transaction

London Stock Exchange XLON

 

1

Details of the person discharging managerial responsibility

a)

Name

Mark Garratt

2

Reason for the notification

a)

Position/status

Group Finance Director

 

b)

Initial notification/amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Full name of the entity

Harvey Nash Group plc

b)

Legal Entity Identifier Code

2138004ULQUX3DQSCV07

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of £0.05 each

ISIN: GB0006573546

c)

Nature of the transaction

Acquisition through Company Performance Share Plan.

e)

Price(s) and Volume(s)

Exercise:

Price(s) per share

Volume(s)

Aggregate Price

£0.05

381,229

£19,061.45

 

 

 

g)

Date of transaction

26 October 2018

h)

Place of transaction

London Stock Exchange XLON

 

Contact:

Mark Garratt, Group Finance Director - 020 7333 0033

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHFEUFMMFASEES
Date   Source Headline
8th Aug 20184:00 pmRNSForm 8.3 - Harvey Nash Group PLC
8th Aug 201811:43 amPRNForm 8.3 - Harvey Nash Group Plc
8th Aug 20188:54 amPRNForm 8.3 - Harvey Nash Group PLC
7th Aug 20183:14 pmRNSForm 8.3 - [Harvey Nash Group plc]
7th Aug 20183:13 pmPRNForm 8.3 - Harvey Nash Group PLC
7th Aug 20181:40 pmRNSForm 8.3 - Harvey Nash Group plc
7th Aug 20187:10 amRNSRecommended Cash Offer
7th Aug 20187:00 amRNSOffer for Harvey Nash Group plc
1st Aug 201812:42 pmRNSDirector/PDMR Shareholding
1st Aug 20187:00 amRNSTotal Voting Rights
3rd Jul 201810:27 amRNSDirector/PDMR Shareholding
2nd Jul 20187:00 amRNSTotal Voting Rights
28th Jun 20183:00 pmRNSResult of AGM
19th Jun 20184:40 pmRNSHolding(s) in Company
18th Jun 20187:00 amRNSNotice of AGM
12th Jun 20187:00 amRNSBlock listing Interim Review
6th Jun 20187:00 amRNSHarvey Nash/KPMG CIO Survey
6th Jun 20187:00 amRNSTrading Update
1st Jun 20182:14 pmRNSDirector/PDMR Shareholding
1st Jun 20187:00 amRNSTotal Voting Rights
15th May 20187:00 amRNSAcquisition of eMenka NV
1st May 20185:37 pmRNSNotification of Transaction by Directors
1st May 20187:00 amRNSTotal Voting Rights
30th Apr 201812:00 pmRNSCapital Markets Day
30th Apr 20188:54 amRNSDirector/PDMR Shareholding
27th Apr 20187:00 amRNSPRELIMINARY RESULTS
4th Apr 20181:20 pmRNSDirector/PDMR Shareholding
3rd Apr 20187:00 amRNSTotal Voting Rights
2nd Mar 20183:41 pmRNSDirector/PDMR Shareholding
2nd Mar 20187:00 amRNSPre-close Trading Update
1st Mar 20187:00 amRNSTotal Voting Rights
1st Feb 20187:00 amRNSTotal Voting Rights
31st Jan 20184:55 pmRNSDirector/PDMR Shareholding
2nd Jan 20187:00 amRNSTotal Voting Rights
21st Dec 20173:00 pmRNSDirector/PDMR Shareholding
12th Dec 20177:00 amRNSBlock listing Interim Review
1st Dec 20177:00 amRNSTotal Voting Rights
30th Nov 20175:13 pmRNSDirector/PDMR Shareholding
1st Nov 20173:50 pmRNSDirector/PDMR Shareholding
1st Nov 20177:00 amRNSTotal Voting Rights
2nd Oct 20177:00 amRNSTotal Voting Rights
29th Sep 20174:52 pmRNSDirector/PDMR Shareholding
29th Sep 20174:33 pmRNSGrant of Share Awards to Directors
28th Sep 20177:02 amRNSAppointment of non-executive director
28th Sep 20177:00 amRNSUnaudited Interim Results
21st Sep 201712:21 pmRNSHolding(s) in Company
12th Sep 20177:00 amRNSAcquisition of Crimson Limited
1st Sep 201711:10 amRNSDirector/PDMR Shareholding
1st Sep 20177:00 amRNSTotal Voting Rights
25th Aug 20171:27 pmRNSNotice of Half Year Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.